Used as a key intermediate in the synthesis of pharmaceutical agents targeting kinase inhibition, particularly in oncology research. Its structure supports the development of small molecule inhibitors that modulate signaling pathways in cancer cells. Commonly employed in medicinal chemistry for constructing dihydropyridopyrimidine-based scaffolds with potential antitumor activity. Also utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity of drug candidates.